港股異動 | L’OCCITANE漲近11% 上半年銷售淨額增逾22%
格隆匯10月23日丨LOCCITANE(0973.HK)高開高走,現報17.68港元,漲幅10.92%,暫成交2041萬港元,最新總市值261億港元。公司昨日公告稱,於2020財年第二季度,集團的銷售淨額按報告匯率計算增長25.5%,按固定匯率計算增長21.7%。2020財年上半年集團的銷售淨額按報告匯率計算增長22.1%,按固定匯率計算增長19.0%。所有品牌及所有主要地區於2020財年第二季度均錄得良好增長是取得令人欣喜表現的原因。主要渠道亦實現增長,其中零售、網上商城、網上合作伙伴及批發銷售是主要貢獻因素。中金研報指,重申公司“跑贏行業”評級,目標價22港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.